# Response to Influenza Vaccination in Pediatric Oncology Patients

> **NCT05384288** · — · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Hematologic Malignancy
- Pediatric Cancer
- Transplant-Related Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05384288
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-07
- **Primary completion:** 2027-12-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05384288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05384288, "Response to Influenza Vaccination in Pediatric Oncology Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05384288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*